OH BRC Brain Technologies Theme supports world’s first epilepsy device fitted into boy’s skull
A study partnership involving University of Oxford researchers from the OH BRC’s Brain Technologies Theme, Great Ormond Street Hospital, University College London and King’s College Hospital were recently involved in running a trial which led to the successful implementation of the world’s first epilepsy device fitted into the skull of a 12-year-old boy.
Oran Knowlson, now aged 13, has Lennox-Gastaut syndrome, a treatment-resistant form of epilepsy which he developed at the age of three. He was invited to take part in the CADET project, which assessed the safety and effectiveness of the new deep brain stimulation device to control seizures for severe epilepsy.
The Picostim neurotransmitter, used in the project, is made by UK company Amber Therapeutics, whose Director Prof. Timothy Denison is contributing Principal Investigator in the OH BRC Brain Technologies Theme.
Published: 27 June 2024
Last reviewed: 6 August, 2024